For these analyses, we used FFPE-derived sequences obtained from 3 ER+ [1–3] and 3 ER- [4–6] breast cancer cases, and compared soft-clipping as well as various mismatch allowances (Fig. 3a, left panel). This evidence concerns the gene ESR1 and breast carcinoma.